SCHEMBL13221850

SCHEMBL13221850

C=c1c2ccc3c4c(ccc(c(=O)n1C)c42)C(=O)N(C)C3=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ USP2 O75604 2/20 0.42
▸ KEAP1 Q14145 2/20 0.42
▸ NFE2L2 Q16236 2/20 0.42
▸ ATM Q13315 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ TERT O14746 7/20 0.41
▸ POLB P06746 1/20 0.41
▸ PRMT1 Q99873 1/20 0.41
▸ STAT3 P40763 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ CASP3 P42574 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35
▸ ADORA2A P29274 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19199222 0.98 TERT (0.44) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL710594 0.81 TERT (0.56) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL12170761 0.81 TERT (0.56) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL9968962 0.81 TERT (0.56) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL9968958 0.81 TERT (0.56) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL29355182 0.81 TERT (0.56) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL30937815 0.77 MEN1 (0.55) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL127059 0.77 MEN1 (0.55) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL12449220 0.73 MEN1 (0.54) MEN1KMT2AALDH1A1USP2KEAP1
SCHEMBL18500360 0.73 TERT (0.49) MEN1KMT2AALDH1A1USP2KEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227475-A1 Asymmetric Fused Aromatic Ring Derivative Containing Sulfonyl Group, Use Thereof, Hydrogen Production Device and Optoelectronic Component NATIONAL TSING HUA UNIVERSITY (TW) 2023-07-20 — — US disclosed
US-20170122893-A1 INTERFACIAL NANOFIBRIL COMPOSITE FOR SELECTIVE ALKANE VAPOR DETECTION NATIONAL SCIENCE FOUNDATION 2017-05-04 — — US disclosed
US-8404705-B2 Naphthalene amidine imides BASF SE (DE) 2013-03-26 — — US disclosed
US-20100202984-A1 Naphthalene amidine imides BASF SE (DE) 2010-08-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227475-A1 Asymmetric Fused Aromatic Ring Derivative Containing Sulfonyl Group, Use Thereof, Hydrogen Production Device and Optoelectronic Component AHR, STS, HAT1 MEN1 3845/4885KMT2A 1341/4885ALDH1A1 590/4885
US-20100202984-A1 Naphthalene amidine imides NES, TXN2, NAT1 MEN1 130/4885KMT2A 4175/4885ALDH1A1 1047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback